Skip to main content
5 September 2025
Last updated:
Friday 5 September 2025
User account anon menu
Login
Register and subscribe
Search
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form
Menu
Breadcrumb
Home
Research Directory
Research Directory
Q3 2017 stock market review: gains and losses shared equally among biotechs
Read more
Artificial intelligence in drug development
Read more
Long-term strategies for immuno-oncology
Read more
Novel immunotherapy arises from collaboration
Read more
A phenotypic share analysis
Read more
EU examines incentives for the pharma industry
Read more
Medigene on a new course
Read more
Using the accelerator and brake to treat cancer
Read more
The patent battle over CRISPR rages on
Read more
Working with patients to accelerate drug development
Read more
Pagination
First page
« First
Previous page
‹‹
…
Page
39
Page
40
Page
41
Page
42
Current page
43
Page
44
Page
45
Page
46
Page
47
…
Next page
››
Last page
Last »
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form
